The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial

BACKGROUND: Interleukin-1 (IL-1) is a key mediator of ischaemic brain injury induced by stroke and subarachnoid haemorrhage (SAH). IL-1 receptor antagonist (IL-1Ra) limits brain injury in experimental stroke and reduces plasma inflammatory mediators associated with poor outcome in ischaemic stroke p...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Navneet, Hopkins, Stephen J, Hulme, Sharon, Galea, James P, Hoadley, Margaret, Vail, Andy, Hutchinson, Peter J, Grainger, Samantha, Rothwell, Nancy J, King, Andrew T, Tyrrell, Pippa J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892121/
https://www.ncbi.nlm.nih.gov/pubmed/24383930
http://dx.doi.org/10.1186/1742-2094-11-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892121/
https://www.ncbi.nlm.nih.gov/pubmed/24383930
http://dx.doi.org/10.1186/1742-2094-11-1

Ejemplares similares